Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the combination of cilostazol with nimodipine to improve outcomes after aneurysmal subarachnoid hemorrhage. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)
  • Nimodipine (Nimodipine)

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Status: NOT_YET_RECRUITING